In this free webinar, learn how bsAb developability data can help predict pairing risk, identify emergent liabilities and de-risk complex biologics earlier. Attendees will gain insight into how ...
Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results